Company / Return on Assets (ROA)
ResMed Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
17.1%
FY2025
5-year range
10.0% / 17.1%
FY2021-FY2025
Trend
+15.3%
vs FY2024
Sector context
#7 of 158
Health Care
What the data says
Among 158 Health Care companies, ResMed is in the top 4% for return on assets (roa). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from 9.8% in FY2019 to 17.1% in FY2025.
Based on SEC 10-K filings.
17.1% in FY2025 with a 5-year CAGR of +3.6%. Top quartile in the Health Care sector.
Improved from 13.3% to 17.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +1.8pp
- 5-Year Change
- +3.6pp
- 10-Year Change
- -
Sector benchmark
Top 4% in Health CareTop 4% of 158This company 17.1% Sector average -2.2%
▼
+881.7% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 15.3% year-over-year.
- Currently 19.3pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.1% | +15.3% |
| FY2024 | 14.9% | +11.8% |
| FY2023 | 13.3% | -13.1% |
| FY2022 | 15.3% | +52.4% |
| FY2021 | 10.0% | -25.9% |
| FY2020 | 13.6% | +37.6% |
| FY2019 | 9.8% | -4.4% |
| FY2018 | 10.3% | +4.4% |
| FY2017 | 9.9% | -8.8% |
| FY2016 | 10.8% | -33.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026